Engraftment syndrome after auto-SCT: Analysis of diagnostic criteria and risk factors in a large series from a single center

Bone Marrow Transplantation

Volumn 45, Issue 9, 2010, Pages 1417-1422

  Carreras, E ^a   Fernandez Aviles F ^a   Silva, L ^a   Guerrero, M ^a   De Larrea, C Fernández ^a   Martinez C ^a   Rosiol L ^a   Lozano, M ^a   Marin P ^a   Rovira, M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

auto SCT; C reactive protein; early complications after SCT; engraftment syndrome

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; BUSULFAN; C REACTIVE PROTEIN; CARMUSTINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIAGNOSTIC TEST; DRUG DOSE REDUCTION; ENGRAFTMENT; ENGRAFTMENT SYNDROME; FEMALE; HEMATOLOGIC DISEASE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; LYMPHOPROLIFERATIVE DISEASE; MAIOLINO CRITERIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFERENCE VALUE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SPITZER CRITERIA; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; C-REACTIVE PROTEIN; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 77956493102     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.363     Document Type: Article

References (14)

1. Lee CK, Gingrich RD, Hohl RJ, Ajram KA. Engraft-ment syndrome in autologous bone marrow and peripheral stem cell transplantation. Bone Marrow Transplant 1995; 16: 175-182.
2. Moreb JS, Kubilis PS, Mullins DL, Myers L, Youngblood M, Hutcheson C. Increased frequency of autoaggression syndrome associated with autologous stem cell transplantation in breast cancer patients. Bone Marrow Transplant 1997; 19: 101-106.
3. Capizzi SA, Kumar S, Huneke NE, Gertz MA, Inwards DJ, Litzow MR et al. Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 1299-1303.
4. Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893-898.
5. Rabinowitz J, Petros WP, Stuart AR, Peters WP. Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support. Blood 1993; 81: 2452-2559.
6. Oyama Y, Cohen B, Traynor A, Brush M, Rodriguez J, Burt RK. Engraftment syndrome: a common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis. Bone Marrow Transplant 2002; 29: 81-85.
7. Dispenzieri A, Lacy MQ, Hayman SR, Kumar SK, Buadi F, Dingli D et al. Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome. Eur J Haematol 2008; 80: 397-406.
8. Maiolino A, Biasoli I, Lima J, Portugal AC, Pulcheri W, Nucci M. Engraftment syndrome following autologous hematopoie-tic stem cell transplantation: definition of diagnostic criteria. Bone Marrow Transplant 2003; 31: 393-397.
9. Carreras E, Saiz A, Marin P, Martinez C, Rovira M, Villamor N et al. CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients. Haematologica 2003; 88: 306-314.
10. Ravoet C, Feremans W, Husson B, Majois F, Kentos A, Lambermont M et al. Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation. Bone Marrow Transplant 1996; 18: 943-947.
11. Fassas AB, Miceli MH, Grazzlutti M, Dong L, Barlogie B, Anaissie E. Serial measurement of serum C-reactive protein levels can identify patients at risk for severe complications following autologous stem cell transplantation. Leuk Lymphoma 2005; 46: 1159-1161.
12. Ortega M, Rovira M, Almela M, de la Bellacasa JP, Carreras E, Mensa J. Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantation. Bone Marrow Transplant 2004; 33: 741-744. (Pubitemid 38499929)
13. Gonzalez-Vicent M, Ramrez M, Sevilla J, Perez A, Fernandez S, Madero L et al. Engraftment syndrome after autologous peripheral blood progenitor cell transplantation in pediatric patients: a prospective evaluation of risk factors and outcome. Bone Marrow Transplant 2004; 34: 1051-1055. (Pubitemid 40028837)
14. Edenfield WJ, Moores LK, Goodwin G, Lee N. An engraftment syndrome in autologous stem cell transplantation related to mono-nuclear cell dose. Bone Marrow Transplant 2000; 25: 405-409.